ARS Pharmaceuticals, Inc. (SPRY)
4.56
+0.20
(+4.59%)
USD |
NASDAQ |
Oct 08, 16:00
4.60
+0.04
(+0.88%)
After-Hours: 07:41
ARS Pharmaceuticals Total Return Level : 4.56 for Oct. 8, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 08, 2026 | 4.56 |
| October 07, 2026 | 4.36 |
| October 06, 2026 | 4.295 |
| October 05, 2026 | 4.29 |
| October 02, 2026 | 4.07 |
| October 01, 2026 | 4.12 |
| September 30, 2026 | 4.31 |
| September 29, 2026 | 4.40 |
| September 28, 2026 | 4.13 |
| September 25, 2026 | 4.08 |
| September 24, 2026 | 4.15 |
| September 23, 2026 | 4.18 |
| September 22, 2026 | 4.48 |
| September 21, 2026 | 4.35 |
| September 18, 2026 | 4.11 |
| September 17, 2026 | 4.15 |
| September 16, 2026 | 4.165 |
| September 15, 2026 | 4.25 |
| September 14, 2026 | 4.50 |
| September 11, 2026 | 4.76 |
| September 10, 2026 | 5.06 |
| September 09, 2026 | 5.23 |
| September 08, 2026 | 5.39 |
| September 04, 2026 | 5.62 |
| September 03, 2026 | 5.67 |
| Date | Value |
|---|---|
| September 02, 2026 | 5.82 |
| September 01, 2026 | 5.77 |
| August 31, 2026 | 6.00 |
| August 28, 2026 | 5.89 |
| August 27, 2026 | 6.03 |
| August 26, 2026 | 6.03 |
| August 25, 2026 | 5.72 |
| August 24, 2026 | 5.35 |
| August 21, 2026 | 5.505 |
| August 20, 2026 | 5.505 |
| August 19, 2026 | 6.38 |
| August 18, 2026 | 6.30 |
| August 17, 2026 | 6.24 |
| August 14, 2026 | 5.65 |
| August 13, 2026 | 6.10 |
| August 12, 2026 | 6.05 |
| August 11, 2026 | 5.95 |
| August 10, 2026 | 5.91 |
| August 07, 2026 | 6.16 |
| August 06, 2026 | 5.55 |
| August 05, 2026 | 5.36 |
| August 04, 2026 | 5.32 |
| August 03, 2026 | 5.46 |
| July 31, 2026 | 5.13 |
| July 30, 2026 | 5.63 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Capricor Therapeutics, Inc. | 8.01 |
| Sionna Therapeutics, Inc. | 4.90 |
| Nektar Therapeutics | 40.80 |
| Vertex Pharmaceuticals, Inc. | 503.25 |
| Ardelyx, Inc. | 3.27 |